The UHG stock price is being closely watched after the company reaffirmed its 2024 guidance. Institutional investors have increased positions, betting on defensive healthcare stocks in uncertain macroeconomic conditions. Short-term resistance stands at $530, with medium-term support at $ Revenue decline stemmed from lower unit volumes, driven partly by a 10.1% drop in average community count and market conditions marked by high mortgage rates and affordability challenges. The average sales price increase and gross margin expansion were supported by the rollout of redesigned floor plans and direct construction cost savings from United Homes’ rebidding initiative. Operating expenses, while slightly lower in dollar terms year over year, remained elevated as a percentage of revenue due to reduced top-line performance. UnitedHealth Group (UNH) , the largest U.S. health insurer, witnessed a turbulent year due to weak Q2 earnings and a lower full-year outlook . However, the companyâs performance is expected to improve in 2026 due to its efforts to reduce costs, improve pricing, and operational efficiency. Thus, this might be the right time to consider UNH stock, especially through exchange-traded funds (ETFs) that offer diversified exposure without the risk of holding the stock directly. Institutional buying pressure persisted last week, pushing the UHG stock price above key moving averages. The 50-day MA is sloping upward, while MACD indicators flash early bullish signals in daily chart setups.
